Mary Lyon Centre at MRC Harwell - Didcot

The Mary Lyon Centre at MRC Harwell: A Leading Research Institute

For those seeking a distinguished and highly respected research institute, the Mary Lyon Centre at MRC Harwell stands as a premier destination. Located in Didcot, Oxfordshire, United Kingdom, the centre is dedicated to groundbreaking research in cancer genetics and related fields. It’s a vital contributor to the global understanding and treatment of various cancers, underpinned by a commitment to innovation and collaborative science.

Location and Accessibility

The Mary Lyon Centre’s physical address is Becquerel Ave, Didcot OX11 0RD, United Kingdom. Its strategic location within the Wellcome Trust’s MRC Harwell Institute provides access to state-of-the-art facilities and a collaborative environment. The centre is exceptionally accessible, ensuring inclusivity for all visitors and staff. Specifically, there’s a wheelchair-accessible car park and a wheelchair-accessible entrance, demonstrating a strong commitment to accommodating individuals with mobility needs. This commitment to accessibility is a key element of their operational philosophy.

About the Mary Lyon Centre

The Mary Lyon Centre, formally known as the Mary Lyon Cancer Centre, is a specialized research unit within the MRC Harwell Institute. It focuses predominantly on BRCA1/2 mutations and other genes associated with inherited breast, ovarian, and other cancers. The centre’s mission is to translate fundamental research discoveries into clinically relevant applications. They achieve this through a multifaceted approach, encompassing basic research, translational studies, and collaborations with pharmaceutical companies and clinical researchers. The centre’s work has significantly advanced our understanding of cancer susceptibility and the development of novel diagnostic and therapeutic strategies. It's a place where scientists meticulously investigate the molecular mechanisms driving cancer development, aiming to ultimately improve patient outcomes.

Specialties and Research Focus

The core expertise of the Mary Lyon Centre revolves around several key areas:

• BRCA1/2 Genetics: A primary focus is on understanding the impact of BRCA1 and BRCA2 mutations on cancer risk and progression.
• Cancer Genomics: The centre employs cutting-edge genomic technologies to identify novel cancer genes and pathways.
• Personalized Medicine: Research explores how genetic information can be used to tailor cancer treatments to individual patients.
• Drug Discovery: The centre is involved in the development of new drugs targeting cancer-related genes.
• Gene Therapy: Investigating the potential of gene therapy approaches for cancer treatment.

Their research utilizes a range of sophisticated techniques, including next-generation sequencing, bioinformatics, cell culture, and animal models. The dedication to employing these advanced technologies underscores their commitment to pushing the boundaries of scientific knowledge.

Contact Information

For further information, you can contact the Mary Lyon Centre at the following details:

• Phone: 1235841000
• Website: har.mrc.ac.uk

Opinions and Reviews

The Mary Lyon Centre consistently receives positive feedback from those who have engaged with it, reflecting its reputation for excellence. Currently, there are 10 reviews on Google My Business, with an average opinion of 4.4/5. These reviews highlight the centre's welcoming atmosphere, the expertise of its researchers, and the impact of its work. Positive comments often emphasize the dedication and collaborative spirit of the team, as well as the centre's commitment to advancing cancer research.

Other Points of Interest

Beyond accessibility, the Mary Lyon Centre offers a stimulating environment for visitors. The facility is designed to foster collaboration and innovation, and its researchers are passionate about their work. The centre regularly hosts seminars, workshops, and conferences, providing opportunities for knowledge exchange and networking within the scientific community. It’s a place where groundbreaking discoveries are made and where the future of cancer research is shaped. Furthermore, the centre values public engagement and strives to communicate its research findings in an accessible manner, contributing to a broader understanding of cancer and its prevention.

In conclusion, the Mary Lyon Centre at MRC Harwell represents a significant force in cancer research. Its strategic location, commitment to accessibility, specialized expertise, and dedication to innovation make it a valuable resource for researchers, clinicians, and the wider community. The consistently positive feedback from users speaks volumes about the quality of the centre’s work and the dedication of its personnel. For anyone seeking to learn more about this vital institution, the website har.mrc.ac.uk provides a wealth of information.